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Abstract  
The 2004 Ministerial Summit on Health Research called on the World Health Organization to to establish a registry network with the intention of 
providing a single access point to identify trials. In 2007 the International Committee of Medical Journal Editors amended their support of this 
initiative stating that only trials registered prospectively on a member registry of the WHO’s Network of Primary Registers would be published. The 
Pan African Clinical Trials Registry (www.pactr.org), was established in early 2007 as the AIDS, TB and Malaria (ATM) Clinical Trials Registry with 
the aim of piloting the concept of a registry that would cater to the specific needs of African trialists. In 2009 the ATM Registry expanded its remit 
to include all diseases for all regions of Africa; The Pan African Clinical Trials Registry became the first and is presently the only African member of 
the World Health Organization’s Network of Primary Registers.  
 
 
 
Pan African Medical Journal. 2011; 9:42  
This article is available online at: http://www.panafrican-med-journal.com/content/article/9/42/full/ 
 
© Amber L Abrams et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited. 
 
 
 
 
 
 
 
 
 
 
 
 
  Pan African Medical Journal – ISSN: 1937- 8688   (www.panafrican-med-journal.com) 
Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net) 
 
Short communication 
Open Access 
 Page number not for citation purposes  2 
Background 
 
Evidence from clinical trials can best answer research questions exploring which medicines or interventions work, and whether they cause harm 
[1]. Since clinical trials provide valuable information, clinicians and researchers should ideally have access to such information in order to inform 
practice. Until recently, very little attention was paid to collecting clinical trial data from the outset of a trial, and more often than not, information 
about trials reached clinicians and other researchers through journal articles and other publications. In the early 1990s there was increasing 
awareness on the issue of selective reporting and publication bias [2,3].  
  
Publication bias is the tendency for negative or neutral trial outcomes to be refused publication while positive and significant trial results are 
preferentially published [4]. This can lead to a skewed presentation of facts in the public record. To overcome this, prospective trial registration 
arose as a means to reduce the effects of publication bias and to encourage greater public disclosure [5]. Prospectively registered trials are housed 
in a clinical trial registry - a database in which important information (administrative and scientific) about planned, in-progress and completed 
trials, adequate to identify that trial’s existence, are stored.  
  
To this end, the Ministerial Summit on Health Research in 2004 called on the World Health Organization (WHO) to establish a registry network with 
the intention of providing a single access point to identify trials. This call was endorsed by 58th World Health Assembly (2005) to which the 
International  Committee  of  Medical  Journal  Editors  (ICMJE)  released  a  statement  of  support.  The  ICMJE  updated  their  statement  in  2007, 
mandating that only trials prospectively registered on a member registry of the WHO’s Network of Primary Registers would be published, making 
trial registration a minimum standard for publication in ICMJE member-journals.  
  
  
The Pan African Clinical Trials Registry 
 
The Pan African Clinical Trials Registry (www.pactr.org), managed by the South African Cochrane Centre at the Medical Research Council, was 
established in early 2007 as the AIDS, TB and Malaria (ATM) Clinical Trials Registry. It aimed to pilot the concept of a registry that would cater to 
the specific needs of African trialists. Since there was no registry on the continent that met the requirements of the ICMJE or the WHO, in late 
2008 the African Vaccine and Regulatory Forum (AVAREF) supported by the WHO-AFRO office recommended that ATM expand its remit beyond its 
disease-specific scope.  
  
In June 2009, the Pan African Clinical Trials Registry was borne out of this expanded remit; the registry now accepts clinical trial applications 
pertaining to all diseases throughout Africa. In July 2009, www.pactr.org became the first and only member of the Network of WHO Primary 
Registers  in  Africa.  Acknowledging  that  researchers  who  conduct  clinical  trials  in  Africa  face  challenges  that  others  may  not  (for  example, 
expensive  or  undependable  internet  access),  www.pactr.org  offers  alternative  modes  of  registration  aside  from  the  internet.  Trials  can  be 
registered free of charge. The central goal of the registry is to collect prospective data on clinical trials in the region, and to display that data in the 
open-access repository online.  
  
In the past year, the registry has experienced substantial growth; applications to the registry have more than doubled. At present, www.pactr.org 
has received 106 applications and 55 trials have completed the registration process and been assigned registration numbers (Figure 1, Figure 2). 
Since one goal of the registry is to assist with minimising publication bias, at present www.pactr.org only accepts trials registered before first 
contact with patients (i.e., prospectively). Of the 106 trial application thirty-four were not registered prospectively which means that the trial 
protocol and methods cannot be tracked. Since trials that have not registered prospectively may have had the opportunity to change certain key 
aspects, like the intended outcomes of the trial, a registry must either notify users of late registration or exclude them from the public repository. 
At the moment our registry deals with trials of this nature in the latter way, but we are moving towards a system that would notify users in an 
effort to collect and publicly display as much trial data as possible.  
  
One of the key objectives for www.pactr.org is to disseminate the registry data and the importance of clinical trial registration as a means of 
transparency, as widely as possible. To overcome the issue of limited internet access, www.pactr.org promoted their existence and presented their 
data at a number of international and local conferences and provided lectures to undergraduate and postgraduate students working in relevant 
fields.  
  
Aside from its primary objective of registering clinical trials on the continent, www.pactr.org aims to increase transparency and self-sufficiency 
amongst national regulatory bodies to encourage clinical trial monitoring in Africa and world-wide. www.pactr.org has begun to work with national 
registries assisting with the establishment of their own local systems of oversight, registration and regulation. With first-hand experience in the 
development  of  our  database  in  this  resource  constrained  region,  www.pactr.org  was  invited  by  the  WHO  and  the  Pan  American  Health 
Organization (PAHO) to facilitate working groups and share our experience (and challenges) with those aiming to develop a Latin American and 
Caribbean regional registry. In addition, in November 2010, www.pactr.org contributed to the first Working Group for the Pan African Clinical Trials 
Alliance (PACTA), a WHO supported initiative that brought together African national representatives with the aim of piloting aspects of registry and 
regulatory development. Promoting the registry and educating trialists on the importance of clinical trial registration has been a central focus of 
2010.  
  
The Child Strategy – Clinical trials and children in Africa  
  
www.pactr.org is also participating in a WHO initiative to develop an Africa-region Child Strategy with the intent of encouraging registration and 
conduct of clinical trials involving children. Through a grant administered by the World Health Organization (WHO) and funded by the Bill and 
Melinda  Gates  Foundation  to  support  the  development  of  regional  Child  Strategies  in  resource-constrained  settings,  staff  of  www.pactr.org 
developed the Africa-region Child Strategy. Since www.pactr.org aims to increase clinical trial registration in Africa by increasing awareness of the Page number not for citation purposes  3 
need to register trials and supporting trialists during registration, partnering with WHO to develop a child strategy falls within the structure and 
aims of www.pactr.org.  
  
In  December  2009,  as  a  sub-project  within  the  registry,  the  Child  Strategy  was  launched.  The  strategy’s  objectives  are:  1)  To  develop  an 
awareness of the global and continental need to conduct and register clinical trials on paediatric trial research within the region; 2) To encourage 
trials in the region to include children as participants; and 3) To increase the number of registered trials including children in Africa.  
  
The child strategy’s dedicated Special Interest Group advises on the development of the research network and focused advocacy activities.  
  
The Africa-region Child Strategy has made efforts to raise awareness of the need to conduct and register clinical trials with children as participants 
through the development of a database of interested stakeholders, through publications and presentations, and the mapping of past child-focused 
trial  activity  in  the  region.  The  child  strategy  began  by  developing  a  network  of  child-focused  stakeholders  including  researchers,  funders, 
institutions,  non-profits,  development  agencies  and  policymakers,  to  increase  collaboration  and  information  sharing.  Attendance  at  relevant 
conferences and agenda-setting meetings has heightened awareness, as have efforts to disseminate relevant research in areas relating to clinical 
trial support and trial environments. At present, 34% of registered trials on www.pactr.org include paediatric trials, with 48% of total registered 
trials dealing with issues that affect maternal and child health.  
  
  
Conclusion 
 
The Pan African Clinical Trials Registry (www.pactr.org) is a regional clinical trials registry born out of the need to fill the gap in this form of 
oversight and as a means of preventing publication bias. The registry itself is growing at a rapid rate, as are activities relating to the goals of the 
registry. The Child Strategy, which aims to increase awareness of the need to conduct research in children, is a sub-project within the registry, and 
is also steadily picking up momentum. The last year of the project has focused on increasing awareness of the role of the registry, and the success 
of these efforts can be seen in the growth of the registry. www.pactr.org is a key resource for researchers, clinicians and policy makers on the 
continent.  
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Figure 1: Total trial applications by disease type 
 
Figure 2: Locations of registered trial sites  
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